We have previously shown that inactivation of mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/ IGF2R) is a common early event in both human liver and breast carcinogenesis. The M6p/Igf2r is imprinted in mice while expression is biallelic in most humans. In this investigation the M6p/Igf2r gene is shown to also be imprinted in the liver of Fischer 344, Lewis and Brown Norway rats. In addition, we have identi®ed mutations in the expressed allele of the M6p/Igf2r in 40% of diethylnitrosamine-initiated rat liver tumors. These results provide further evidence that the M6P/IGF2R functions as a liver tumor suppressor gene. They also suggest that mice and rats would be more sensitive than humans to those hepatocarcinogens in which the M6p/ Igf2r is mechanistically involved in transformation since one rather than two alleles would need to be inactivated.
Introduction
Approximately 60% of the chemicals determined by the National Toxicology Program to be carcinogenic in rats and mice give rise to liver tumors (Haseman et al., 1987) . We have postulated that the carcinogenic eect of at least some of these compounds results from their ability to release hepatocytes from normal hepatic growth controls (Jirtle et al., 1994; Mills et al., 1995) . The mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) is a multifunctional cell membrane-associated glycoprotein that is involved in regulating the intracellular tracking of lysosomal enzymes (Kornfeld, 1992; Dahms, 1996) , the degradation of the mitogen, insulin-like growth factor 2 (IGF2; Morgan et al., 1987) , and the activation of the mitoinhibitor, transforming growth factor beta (TGFb; Dennis and Rifkin, 1991) . It has also recently been shown to be a high anity binding receptor for retinoic acid, an agent known to have diverse biological eects in both embryogenesis and oncogenesis (Kang et al., 1997) . Thus, important homeostatic controls regulating cell proliferation and apoptosis would be lost with the inactivation of the M6P/ IGF2R, suggesting that this receptor normally functions to inhibit tumor formation.
We have shown immunohistochemically that a large percentage of rodent liver tumors promoted with phenobarbital (PB; Jirtle et al., 1994) , Wy-14,643 (Mills et al., 1995) and unleaded gasoline (Moser et al., 1996) lack the M6p/Igf2r. Furthermore, the M6P/ IGF2R is frequently mutated in human liver and breast tumors (De Souza et al., 1995a,b; Hankins et al., 1996; Yamada et al., 1997) , and it is a target for mismatch repair de®ciency in colon, gastric and endometrial tumors Ouyang et al., 1997) . The M6p/Igf2r is imprinted in mice with only the maternal allele being transcribed (Barlow et al., 1991) . In contrast, genomic imprinting of this gene is a polymorphic trait in humans with most people having biallelic expression (Kalscheuer et al., 1993; Xu et al., 1993) . The purpose of this study was to determine if the M6p/Igf2r gene is imprinted in rats, and if so, whether the expressed allele is mutated in diethylnitrosamine (DEN) initiated and DEN-initiated, PBpromoted liver tumors. The results of this investigation demonstrate that the M6p/Igf2r locus is imprinted in rats, and the expressed allele is frequently mutated in chemical carcinogen-induced rat hepatocellular carcinomas (HCCs).
Results and Discussion
Genomic imprinting refers to a genetic phenomenon where certain genes are molecularly marked such that one of the parental alleles is transcriptionally silenced (for reviews see Barlow, 1995; Franklin et al., 1996; De Souza et al., 1997) . In mice the M6p/Igf2r gene is expressed only from the maternal allele (Barlow et al., 1991) , whereas in humans, imprinting at the M6P/ IGF2R locus is a polymorphic trait (Kalscheuer et al., 1993; Xu et al., 1993) . Recent evidence also indicates that the M6P/IGF2R functions as a tumor suppressor gene in a variety of human tumors (De Souza et al., 1995a; b; Hankins et al., 1996; Yamada et al., 1997; Souza et al., 1996; Ouyang et al., 1997) . Thus, animals in which the M6p/Igf2r is imprinted would be expected to be more sensitive than humans to those carcinogens in which the M6p/Igf2r is mechanistically involved in the transformation process .
To determine whether genomic imprinting of the M6p/Igf2r plays a role in rat hepatocarcinogenesis, we ®rst determined whether the M6p/Igf2r locus is imprinted in rat liver by utilizing a G/C DNA sequence polymorphism found in exon 48 of Lewis and F344 rats (Figure 1a and b) . We have shown by reverse transcription-polymerase chain reaction (RT ± PCR) and direct sequencing the presence of a single M6p/Igf2r RNA species in rat liver (Figure 1c) , and that expression is from the maternal allele irrespective of whether the Lewis or Fischer 344 (F344) rat is the mother. The presence of a single RNA species that is expressed only from the maternal allele demonstrates that the M6p/Igf2r gene is imprinted in the liver of rats as in mice. We have also observed genomic imprinting of the M6p/Igf2r gene in the liver of Brown Norway rats (data not shown).
The precise molecular mechanism for genomic imprinting of the M6p/Igf2r is presently unknown. Methylation of a CpG rich region in intron 2 of the expressed maternal M6p/Igf2r allele has been shown to carry the imprint signal for this gene (StoÈ ger et al., 1993; Wutz et al., 1997) . Furthermore, this region appears to normally function as the promoter of an antisense transcript that is expressed only from the repressed paternal allele indicating that a form of expression competition regulates imprinting of the M6p/Igf2r gene (Wutz et al., 1997) . Whether intron 2 of the M6p/Igf2r gene in rats also contains a maternal speci®c CpG methylation as observed in mice is presently being investigated.
Mutations in the M6p/Igf2r allele were seen in 2/6 (33%) liver tumors that arose in F344 rats treated with DEN alone, while 5/11 (45%) liver tumors were mutated in F344 rats initiated with DEN and then promoted with PB; this dierence in mutational frequency is not statistically signi®cant (P40.1). Of the 17 liver tumors analysed, genomic deletions were observed in 6/17 tumors (Figures 2 and 3), and a point mutation was observed in 1/17 tumors ( Figure 4) . Thus, the overall mutation frequency of the M6p/Igf2r gene in these liver tumors is 7/17 or 41%. Additionally, examination of seven DEN-induced liver tumors from Lewis6F344 F 1 hybrid rats revealed monoallelic expression in the M6p/Igf2r in all of the tumors (i.e. imprinting was maintained). Three of these tumors (43%) had deletions in the maternally expressed allele of the M6p/Igf2r gene (data not shown). This mutation frequency is not signi®cantly dierent (P40.1) from that observed in the F344 rats. This is the ®rst report of mutations in the imprinted M6p/Igf2r tumor suppressor gene in rodent liver tumors induced with a chemical carcinogen.
Deletions T1 to T4¯ank the region of the M6p/Igf2r that contains the IGF2 binding domain (Figures 2 and  3 ). These deletions remove 477, 802, 861 and 852 bases at the RNA level, respectively. Deletions in T1 to T3 are in frame leading to predicted M6p/Igf2r protein lengths of 2322, 2197 and 2192 amino acids rather than the full length 2480 amino acid receptor protein. The deletion in T4 is out of frame leading to a stop codon after 1420 amino acids. This truncated receptor would be expected to be secreted into the extracellular space since it lacks a transmembrane domain. These four deletions result in the loss of the IGF2 binding site. Mutations in this region have also been frequently observed in both human HCCs and breast tumors (De Souza et al., 1995b; Hankins et al., 1996; . The combined frequency for mutations in this region in rat and human tumors is 11/33 (33%) suggesting that degradation of IGF2 by the M6P/ IGF2R is important in maintaining a normal cell phenotype. This supports recent ®ndings of Ludwig et al. (1996) who demonstrated that in mutant mice, Igf2 turnover during embryogenesis is regulated by the M6p/Igf2r, and targeted disruption of the M6p/Igf2r results in Igf1r overstimulation by Igf2. Deletions in tumors T5 and T6 involve a loss of genetic material in the 5' end of the M6p/Igf2r gene ( Figure 3) . DNA is lost from exon 3 to exon 27 in tumor 5. This would result in a truncated RNA that would code for a putative protein that is shifted out of reading frame after 134 amino acids and is terminated with a stop codon after 163 amino acids. Interestingly, tumor 6 is deleted from 15 base pairs into the open reading frame to exon 26 leading to a putative protein of seven amino acids. This deletion also includes intron 2 which is postulated to contain the maternal speci®c imprint mark in mice (StoÈ ger et al., 1993; Wutz et al., 1997) .
Recently an 8 G polynucleotide repeat in the M6P/ IGF2R gene was reported to be a target for microsatellite instability in human gastric, colon and endometrial tumors Ouyang et al., 1997) . No mutations were seen in the rat microsatellite homologue of this human sequence in these rat liver tumors. In addition, no point mutations were detected in the IGF2 and M6P binding domains or in the transmembrane and intracellular tracking regions (Kornfeld, 1992; Dahms, 1996) . However, a T : A?A : T transversion was found in one liver tumor that substituted an arginine for a stop codon in exon 48 resulting in the addition of 57 amino acids to the full length protein (Figure 4) . Such a change would be expected to alter the intracellular tracking of the receptor since the tracking signals are at the Cterminal portion of the receptor (Kornfeld, 1992) . (Kornfeld, 1992; Dahms, 1996) It is possible that other mutations present in the M6p/Igf2r gene in these rat liver tumors have gone undetected. Because of the large size of the M6p/Igf2r locus (&100 Kbp) and corresponding mRNA (9.1 Kb) (Szebenyi and Rotwein, 1994) , only those regions of the mRNA known to code for sites involved in receptor function (Kornfeld, 1992; Dahms, 1996) were directly sequenced for mutations. Genomic deletions that started or ®nished outside the coding region or deletions in the 3' untranslated region of the receptor, which may aect RNA stability or intracellular tracking, would not be identi®ed by the screening strategy employed in this study. Also, we did not screen for mutations or methylation changes in that region of intron 2 reported to control genomic imprinting in mice (StoÈ ger et al., 1993; Wutz et al., 1997) or in the promoter region that controls gene expression. Thus, the frequency of mutations described in this report is the minimum present in DEN-initiated rat liver tumors.
In conclusion, the data reported here provides further evidence that the M6P/IGF2R functions as a liver tumor suppressor gene. Furthermore, the imprinted M6p/Igf2r represents a susceptibility locus for chemical carcinogens in mice and rats since only one allele needs to be inactivated. In contrast, humans would be expected to be less susceptible to the loss of M6P/IGF2R function since most people have biallelic expression. These ®ndings raise potentially important regulatory issues concerning the extrapolation of carcinogenesis results from rodents to humans.
Materials and methods

Animals
Male F344 and Lewis6F344 F 1 hybrid rats weighing 80 ± 100 g (Charles River Laboratories, Raleigh, NC) were fed Purina rodent chow No. 5010 (PMI Feeds, St. Louis, MO) and given water ad libitum. They were maintained in a temperature-and humidity-controlled room under a 12 h light/dark cycle. Following 1 week of acclimatization, the rats were treated with DEN (Sigma, St. Louis, MO) at 50 p.p.m. in the drinking water for 1 month. The animals were then randomized; one half of the animals were given regular water while the remaining animals received 0.1% PB (Mallinckrodt, Paris, KY) in their drinking water for 4 months. The exposure regimen resulted in the formation of liver tumors 1 ± 2 cm in diameter in both treatment groups, but there were more in the PB-promoted animals than in the non-promoted animals. After 4 months of PB treatment, all the rats were killed. Tumors and normal liver tissue surrounding the tumors were excised and snap frozen in liquid nitrogen for RNA extraction. All animal use was in full compliance with NIH guidelines for humane care, and was approved by the Duke University Medical Center Animal Use Committee.
Determination of genomic imprinting
The imprinted status of the M6p/Igf2r in rat liver was determined by utilizing a single base sequence polymorphism between F344 and Lewis rats in the 5' end of exon 48 (base number 7176) (Figure 1 ). DNA and total RNA were simultaneously extracted from F3446Lewis and Lewis6F344 F 1 hybrid rat livers (Harlan Sprague Dawley, Indianapolis, IN) by the RNA/DNA-Stat-60 method (TelTest B, Friendswood, TX), a modi®cation of the single-step acid guanidinium thiocyanate-phenol-chloroform method. Brie¯y, 50 mg of liver tissue was homogenized using a rotor/stator homogenizer in 1 ml of RNA STAT-60 reagent until disaggregated. After 5 min at room temperature, 200 ml of chloroform was added, the homogenate was vortexed for at least 15 s, stored at room temperature for 2 ± 3 min, and then centrifuged at 12 000 g for 15 min at 48C. After centrifugation the upper, aqueous phase was transferred to a 1.5 ml microcentrifuge tube, 0.8 ml of isopropanol added and the mixture incubated at room temperature for 5 ± 10 min. Following a further centrifugation at 12 000 g for 15 min at 48C, the supernatant was removed, the RNA pellet washed with 75% ethanol, vortexed and centrifuged at 7500 g for 5 min at 48C. The supernatant was discarded and the RNA pellet air-dried before dissolution in 50 ± 100 ml of water. For DNA isolation, 800 ml of DNA STAT-60 reagent was added to the lower, nonaqueous phase obtained after the initial centrifugation of the tissue homogenate. This sample was vortexed for at least 15 s, stored at room temperature for 2 ± 3 min and centrifuged at 12 000 g for 15 min at 48C. The DNA isolation then followed the same protocol as that for RNA. Forward (GTCAGCAAGGAGGAGGAGACAG) and reverse (GGGGCTGTGAGCTTTCCACCTC) primers, and genomic DNA as template, were used to amplify the portion of exon 48 containing the polymorphism by the PCR conditions described below.
For RT ± PCR, ®rst strand cDNA synthesis was performed using: 50 mM Tris-HCl, pH 8.3, 75 mM KCl, 3 mM MgCl 2 , 10 mM DTT, 0.5 mM 4dNTP mix, 1 mM reverse primer (GCTGAAGTCTTATTTGGTTGGAG), 2 ± 5 mg total RNA, and 200 units M-MLV reverse transcriptase (Gibco BRL, Gaithersburg, MD) in a total volume of 20 ml. RNA was mixed and heated to 658C for 10 min, and then chilled on ice prior to the addition of the other components. The ®nal mixture was incubated at 378C for 60 min and then at 658C for 10 min. Protein and excess primer were removed from the RT reaction using QIAquick PCR Puri®cation columns (Qiagen, Chatsworth, CA) with the cDNA resuspended in 50 ml H 2 O.
To ensure that PCR ampli®cation and subsequent puri®cation of cDNA was not contaminated with genomic DNA, RT ± PCR primers were designed to span intron sequences. Thus, ampli®cation of genomic DNA would generate a template containing introns whereas these introns would be absent in the smaller templates generated from cDNA. The reaction conditions for polymerase chain reaction (PCR) were as follows: 10 mM Tris-HCl, pH 8.3
(at 258C), 50 mM KCl, 1.5 mM MgCl 2 , 200 mM 4dNTP mix, 200 nM forward (TGTGGACTTTGATGATGAGAATGC) and reverse (GGGGCTGTGAGCTTTCCACCTC) primers, 5 ml RT template, and 2.5 units Taq DNA polymerase (Perkin Elmer, Norwalk, CT) in a total volume of 100 ml. Hot-start PCR was carried out under the following conditions: 1 min denaturing at 948C, 1 min annealing at 608C, and 1 min extension at 728C for 35 cycles with an additional 5 min extension for cycle 35 on a DNA Thermal Cycler (Perkin Elmer, Norwalk, CT). The cDNA generated by PCR was characterized by agarose gel electrophoresis, and the expected bands gel extracted using a QIAquick Gel Extraction kit (Qiagen, Chatsworth, CA). 10 ml of the gel extracted material was used as a template for direct PCR sequencing using the AmpliCycle kit (Perkin Elmer, Norwalk, CT).
Identi®cation of M6p/Igf2r mutations RT ± PCR MisMatch detection Ambion, Austin TX) and direct PCR sequencing were used to determine the mutational frequency in the 9.1 Kb mRNA derived from rat liver tumors. The protein coding region of the cDNA was initially screened for mutations by MisMatch detection as previously described (De Souza et al., 1995b) . In addition, direct PCR sequencing was used to screen the translational start site, the known IGF2 and M6P protein binding regions, the transmembrane domain and the intracellular tracking regions for genetic alterations (Kornfeld, 1992; Dahms, 1996) . For RT ± PCR and direct PCR sequencing, ®rst strand cDNA synthesis and PCR were performed by the methods described above. Brie¯y, ®rst round primers were used to amplify overlapping 2 Kb fragments, which formed the templates for overlapping nested 500 bp second round ampli®cations. For nested PCR ampli®cations, excess primers and other contaminants were removed from the ®rst round ampli®cation using QIAquick PCR Puri®cation columns (Qiagen, Chatsworth, CA). The DNA generated by PCR was characterized by agarose gel electrophoresis and the expected bands gel extracted using a QIAquick Gel Extraction kit (Qiagen, Chatsworth, CA). Ten ml of the gel extracted material was used as a template for direct PCR sequencing using the AmpliCycle kit (Perkin Elmer, Norwalk, CT). Because the ®delity of Taq DNA polymerase is such that errors can be introduced during the PCR process, a number of precautions were taken to address this potential problem. Mutant templates were ampli®ed in two or more independent PCR reactions. In all cases the corresponding normal template was ampli®ed in parallel with the tumor template, and the tumor mutations were con®rmed by direct sequencing in both directions.
